Humana Inc: Form 10-K for the period ended Dec 31, 2012
Filed with the SEC on Feb 22, 2013 and accepted by EDGAR at Feb 21, 2013, 20:52 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-10-01 to 2012-12-31 | $9.56bn | us-gaap:Revenues |
| Revenue | 12 months2012-01-01 to 2012-12-31 | $39.13bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2012-01-01 to 2012-12-31 | $5.83bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2012-01-01 to 2012-12-31 | $2.02bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2012-01-01 to 2012-12-31 | $105.0m | us-gaap:InterestExpense |
| Income tax | 12 months2012-01-01 to 2012-12-31 | $689.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-10-01 to 2012-12-31 | $192.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2012-01-01 to 2012-12-31 | $1.22bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-10-01 to 2012-12-31 | $1.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2012-01-01 to 2012-12-31 | $7.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-10-01 to 2012-12-31 | $1.21 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2012-01-01 to 2012-12-31 | $7.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2012-01-01 to 2012-12-31 | 163,457,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2012-01-01 to 2012-12-31 | $1.92bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2012-01-01 to 2012-12-31 | $410.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2012-01-01 to 2012-12-31 | $165.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2012-01-01 to 2012-12-31 | $518.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-12-31 | $1.31bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-12-31 | $11.71bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-12-31 | $19.98bn | us-gaap:Assets |
| Current liabilities | At period end2012-12-31 | $6.38bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-12-31 | $11.13bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-12-31 | $2.61bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2012-12-31 | $8.85bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-13-069911. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.